Clincosm LogoSign in Get a demo

recurrent pancreatic cancer

Showing 1 - 25 of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • sorafenib tosylate
  • +4 more
  • Aurora, Colorado
  • +1 more
Sep 8, 2022

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Active, not recruiting
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +3 more
  • 6,8-bis(benzylthio)octanoic acid
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 22, 2021

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
Has Results
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +3 more
  • metformin hydrochloride
  • +4 more
  • Cleveland, Ohio
  • +1 more
Aug 9, 2021

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in Bronx

Completed
Has Results
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • Bronx, New York
    Montefiore Medical Center
May 18, 2021

Recurrent Pancreatic Cancer Trial in Shanghai (Tislelizumab, Nab paclitaxel, Gemcitabine)

Recruiting
  • Recurrent Pancreatic Cancer
  • Shanghai, China
    Changhai Hospital
May 25, 2021

Gastrinoma, Glucagonoma, Insulinoma Trial in Stanford (Capecitabine, Temozolomide, Bevacizumab)

Completed
Has Results
  • Gastrinoma
  • +8 more
  • Stanford, California
    Stanford University Medical Center
Apr 8, 2021

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in San Francisco, Columbus

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +3 more
  • erlotinib hydrochloride
  • +2 more
  • San Francisco, California
  • +1 more
Jul 29, 2020

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +3 more
  • metformin hydrochloride
  • stereotactic radiosurgery
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Seidman Cancer Ce
Jun 24, 2020

Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Chicago (biological,

Completed
Has Results
  • Duct Cell Adenocarcinoma of the Pancreas
  • +3 more
  • ipilimumab
  • +2 more
  • Chicago, Illinois
    Northwestern University
Feb 24, 2020

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • Scottsdale, Arizona
  • +2 more
Apr 4, 2019

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Australia, Singapore, United

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +2 more
  • Scottsdale, Arizona
  • +8 more
Mar 20, 2019

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • 6,8-bis(benzylthio)octanoic acid
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 26, 2018

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • La Jolla, California
  • +13 more
Aug 30, 2018

Recurrent Melanoma, Recurrent Pancreatic Cancer, Recurrent Renal Cell Cancer Trial in Winston-Salem (siRNA-transfected

Completed
  • Recurrent Melanoma
  • +11 more
  • siRNA-transfected peripheral blood mononuclear cells APN401
  • laboratory biomarker analysis
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jul 2, 2018

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +7 more
  • Alhambra, California
  • +16 more
Jan 5, 2018

Adenocarcinoma of the Pancreas, Pancreatic Cancer, Recurrent Pancreatic Cancer Trial in Toronto (eribulin mesylate)

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +5 more
  • eribulin mesylate
  • Toronto, Ontario, Canada
    University Health Network-Princess Margaret Hospital
Sep 19, 2017

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Advanced Adult Primary Liver Cancer Trial in Nashville (cetuximab,

Completed
  • Adenocarcinoma of the Colon
  • +66 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Sep 28, 2015

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in United States (vismodegib,

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +2 more
  • Beverly Hills, California
  • +25 more
Jul 20, 2015

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Cleveland (dasatinib,

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +2 more
  • Cleveland, Ohio
    Case Western Reserve University
Apr 14, 2015

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage I Pancreatic Cancer Trial (bevacizumab, gemcitabine HCl,

Withdrawn
  • Adenocarcinoma of the Pancreas
  • +4 more
  • (no location specified)
Apr 27, 2015

Recurrent Colon Cancer, Extensive Stage Small Cell Lung Cancer, Stage III Pancreatic Cancer Trial run by the NCI (Detox-B

Completed
  • Recurrent Colon Cancer
  • +13 more
  • Detox-B adjuvant
  • ras peptide cancer vaccine
  • Bethesda, Maryland
    Medicine Branch
Apr 27, 2015

Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Buffalo (dovitinib

Withdrawn
  • Duct Cell Adenocarcinoma of the Pancreas
  • +4 more
  • dovitinib lactate
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 8, 2015

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Aurora, Denver, Baltimore

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +2 more
  • gamma-secretase/Notch signalling pathway inhibitor RO4929097
  • Aurora, Colorado
  • +2 more
Nov 19, 2014

Intraductal Papillary Mucinous Tumor of the Pancreas, Recurrent Pancreatic Cancer, Stage IA Pancreatic Cancer Trial in Orange

Terminated
Has Results
  • Intraductal Papillary Mucinous Neoplasm of the Pancreas
  • +6 more
  • erlotinib hydrochloride
  • +6 more
  • Orange, California
    University of California Medical Center At Irvine-Orange Campus
Oct 7, 2014

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Rochester (gemcitabine HCl,

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Jul 23, 2014